<DOC>
	<DOCNO>NCT02697305</DOCNO>
	<brief_summary>Branched chain amino acid ( BCAA ) know exert insulinogenic effect . Whether effect mediate incretins ( GLP-1 , GIP ) know . The aim study show incretin effect BCAA , i.e . whether oral administration BCAA elicit high insulin incretin response compare IV route dose BCAA . Eighteen healthy , male subject participate three test : IV application BCAA solution ( 30.7±1.1 g BCAA , IV BCAA ) second oral ingestion BCAA capsule dose ( ORAL BCAA ) third experiment oral placebo ( PLACEBO ) . Glucose , insulin , GLP-1 , GIP , valine , leucine isoleucine level measure time interval 4 h .</brief_summary>
	<brief_title>Incretin Effects Branched Chain Amino Acids</brief_title>
	<detailed_description>Study protocol : Three test conduct different occasion ( least 7 day ) . First test ( IV BCAA test ) comprise IV application BCAA solution ( Nutramin VLI 3 % , Fresenius Kabi , KGaA , Germany ; Leucine 43 % , Isoleucine 24 % , Valine 33 % ) total dose 0,4 g/kg 2 h infusion ( mean solution volume 1023±34.6mL , mean total dose BCAA 30.7±1.1g ) respect maximum recommend infusion rate . Second test ( ORAL BCAA test ) comprise oral ingestion BCAA capsule ( BCAA capsule , Reflex Nutrition , UK , Brighton ; Leucine 50 % , Isoleucine 25 % , Valine 25 % ) single dose 0.4g/kg ( mean total dose BCAA 30.7±1.1 g ) administer 30 , wash 500mL tap water . Third test ( ORAL PLACEBO test ) comprise oral ingestion placebo capsule ( methylcellulose , University hospital institution pharmacy prepare ) single dose 0.4 g/kg administer 30 , wash 500 mL tap water . The content placebo capsule weight pack identically BCAA capsule . Nor participants staff administer capsule carry protocol know capsule content randomize double-blinded setting could maintain . Blood analysis : Basal peripheral venous blood drawn subject 12 h fasting ( -15 min ) time 0 , 15 , 30 , 45 , 60 , 90 , 120 , 150 , 180 , 210 , 240 min throughout intervention . Plasma immediately separate sample frozen -80 °C analysis perform . For GLP-1 GIP analysis BD P800 Blood Collection System use coat develop preserve metabolic peptide blood ( cocktail protease , esterase DPP-IV inhibitor , anticoagulant 3,6 mg di-potassium ethylenediaminetetraacetic acid ( K2EDTA ) , Becton , Dickinson Co. , New Jersey , USA ) . Parameters glucose homeostasis assess : plasma glucose use hexokinase reaction ( Konelab Glucose analyzer , Thermo Fisher Scientific , Oy. , Finland ) serum insulin use solid phase competitive chemiluminescent enzyme immunoassay ( Immulite 2000 , Siemens A.G. , Germany ) . Commercially available ELISA kit use GLP-1 GIP analysis : GLP-1 Immuno-Biological Laboratories ( Immuno-Biological Laboratories , Gunma , Japan ) GIP Millipore ( EMD Millipore Corporation , Bilerica , MA , USA ) . Serum level BCAAs determine method capillary electrophoresis ( CE ) contactless conductivity detection , already describe detail [ 18 ] . Shortly : CE measurement carry use HP3DCE system ( Agilent Technologies , Waldbronn , Germany ) equip built-in contactless conductivity detector . Separation take place fused-silica capillary ( 31.4 cm total length , 14.7 cm detector , 25 μm inside diameter , 363 μm outside diameter , Composite Metal Services , UK ) control temperature 25 °C . The inner surface capillary cover use INST coat solution ( Biotaq , U.S.A. ) prevent electro-osmotic flow first use [ 19 ] . The CE separation perform optimize background electrolyte composition 3.2 mol/l acetic acid 20 % v/v methanol , pH 2.0 . The achieved separation time 125 electric field intensity 0.96 kV/cm simultaneous application hydrodynamic pressure 50 mbar . The separation efficiency blood serum equal 461,000 plates/m valine isoleucine , 455,000 plates/m leucine ; detection limit equal 0.4 µM three amino acid . The relative standard deviation value repeatability migration time equal 0.1 % measurement single day 0.3 % measurement different day ; relative standard deviation value repeatability peak area equal 2.3 - 2.6 % measurement single day 2.7 - 4.6 % measurement different day . Blood sample collect test tube contain ethylenediaminetetraacetic acid ( EDTA ) . The obtained serum sample store freezer -20 °C analysis . Prior analysis , unfrozen serum sample deproteinized mix 250 µl serum 750 µL acetonitrile . Deproteinization perform Eppendorf tube shake 30 . Then serum sample centrifuge acceleration 4 g 45 ; 800 µL obtain supernatant take CE analysis . Statistical analysis : Data present text , table figure mean ± standard error mean ( SEM ) value p &lt; 0.05 consider statistically significant . Secretion response insulin , GIP , GLP-1 , valine , leucine isoleucine calculate subject incremental area curve ( iAUC ) . iAUCs calculation allow different individual baseline value . iAUCs calculate use trapezoid model , 0-240 min glucose , insulin BCAA 0-120 GLP-1 GIP . All individual value baseline exclude subject respective study reference . Secretion response glucose calculate decremental AUC ( dAUC ) response predominantly negative . All individual value baseline exclude case . Data statistical comparison iAUC individual value test normality normally distribute data , sample compare use general linear model ANOVA Bonferroni 's multiple comparison test statistical significance difference group . Repeated measure ANOVA test use assess time effect every respective treatment . Mixed model ANOVA use assess treatment time vs treatment effect . Differences group identify use Bonferroni 's multiple comparison test . GraphPad Prism , release 5.03 ( GraphPad software , San Diego ) use perform statistical procedure .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Glucose Metabolism Disorders</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>healthy volunteer age 18 year , obesity , chronic disease relate energy metabolism ( particularly diabetes , thyreopathy , hypertension , dyslipidemia , atherosclerosis etc . ) , chronic medication , smoke regular alcohol consumption</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Insulin response</keyword>
	<keyword>Incretin effect</keyword>
	<keyword>GLP-1</keyword>
	<keyword>GIP</keyword>
	<keyword>Valine</keyword>
	<keyword>Leucine</keyword>
	<keyword>Isoleucine</keyword>
	<keyword>Branched chain amino acid</keyword>
</DOC>